Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Resolving the immune landscape of human prostate at a single-cell level in health and cancer.
Tuong ZK, Loudon KW, Berry B, Richoz N, Jones J, Tan X, Nguyen Q, George A, Hori S, Field S, Lynch AG, Kania K, Coupland P, Babbage A, Grenfell R, Barrett T, Warren AY, Gnanapragasam V, Massie C, Clatworthy MR. Tuong ZK, et al. Among authors: berry b. Cell Rep. 2021 Dec 21;37(12):110132. doi: 10.1016/j.celrep.2021.110132. Cell Rep. 2021. PMID: 34936871 Free PMC article.
Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate Cancer: A National Population-Based Study.
Sujenthiran A, Parry M, Nossiter J, Berry B, Cathcart PJ, Clarke NW, Payne H, van der Meulen J, Aggarwal A. Sujenthiran A, et al. Among authors: berry b. Clin Oncol (R Coll Radiol). 2020 Aug;32(8):501-508. doi: 10.1016/j.clon.2020.02.004. Epub 2020 Mar 3. Clin Oncol (R Coll Radiol). 2020. PMID: 32143901
Toxicity of Pelvic Lymph Node Irradiation With Intensity Modulated Radiation Therapy for High-Risk and Locally Advanced Prostate Cancer: A National Population-Based Study Using Patient-Reported Outcomes.
Parry MG, Nossiter J, Cowling TE, Sujenthiran A, Berry B, Cathcart P, Clarke NW, Payne H, van der Meulen J, Aggarwal A. Parry MG, et al. Among authors: berry b. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1196-1203. doi: 10.1016/j.ijrobp.2020.07.031. Epub 2020 Jul 24. Int J Radiat Oncol Biol Phys. 2020. PMID: 32717261
Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: A national population-based study.
Parry MG, Nossiter J, Cowling TE, Sujenthiran A, Berry B, Cathcart P, Clarke NW, Payne H, van der Meulen J, Aggarwal A. Parry MG, et al. Among authors: berry b. Radiother Oncol. 2021 Feb;155:48-55. doi: 10.1016/j.radonc.2020.10.019. Epub 2020 Oct 17. Radiother Oncol. 2021. PMID: 33075390
Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based Study.
Parry MG, Nossiter J, Sujenthiran A, Cowling TE, Patel RN, Morris M, Berry B, Cathcart P, Clarke NW, Payne H, van der Meulen J, Aggarwal A. Parry MG, et al. Among authors: berry b. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1219-1229. doi: 10.1016/j.ijrobp.2020.11.023. Epub 2020 Dec 3. Int J Radiat Oncol Biol Phys. 2021. PMID: 33279595
429 results